Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Cholangiocarcinoma 3Glioblastoma 2Upper Tract Urothelial Carcinomas 1Squamous Cell Carcinoma of Head and Neck 1Renal Pelvis and Ureter Urothelial Carcinoma 1Papillomavirus Infections 1Oncogenic osteomalacia 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Hypophosphatemia 1Hematologic Neoplasms 1Glioma 1Breast Neoplasms 1Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

pembrolizumab 4Cisplatin 4Gemcitabine 3Carboplatin 3Docetaxel 2Bupropion 2tocilizumab 1tislelizumab 1spartalizumab 1infigratinib 1etoposide phosphate 1cc-486 1avelumab 1Zoledronic Acid 1Vorinostat 1Varenicline 1Tobacco Use Cessation Devices 1Radiotherapy, Intensity-Modulated 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Oral Hygiene 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Ifosfamide 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nasopharyngeal Neoplasms × infigratinib × Clear all
NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

University of Chicago

Phase 2 Terminated
1 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡